• Sign In
  • Sign Out
  • My Account
Subscribe
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
  • Special reports
Clarivate
  • Data Snapshots
  • BioWorld
  • BioWorld MedTech
  • Infographics: Dynamic digital data analysis
  • Special reports
  • Infographics: Dynamic digital data analysis
  • Trump administration impacts
  • Biopharma M&A scorecard
  • BioWorld 2024 review
  • BioWorld MedTech 2024 review
  • BioWorld Science 2024 review
  • Women's health
  • China's GLP-1 landscape
  • PFA re-energizes afib market
  • China CAR T
  • Alzheimer's disease
  • Israel
  • Rise of obesity
  • Radiopharmaceuticals
  • Biosimilars
  • Aging
  • IVDs on the rise
  • Coronavirus
  • Artificial intelligence

BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Israel
    • Rise of obesity
    • Radiopharmaceuticals
    • Biosimilars
    • Aging
    • IVDs on the rise
    • Coronavirus
    • Artificial intelligence

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
Home » Newsletters » BioWorld Science

BioWorld Science

Dec. 7, 2015

View Archived Issues

Cyclic pyranopterin monophosphate substitution in neonates with molybdenum cofactor deficiency

Read More

Preclinical findings for NanoBio's intranasal nanoemulsion adjuvanted chlamydia vaccine

Read More

Morphotek and University of Wisconsin-Madison to study farletuzumab

Read More

Interim data released from phase II study of KRN-23 for XLH, phase III study enrolls first patient

Read More

Pluristem and Fukushima Medical University sign MOU for collaboration to study PLX-R18 for ARS

Read More

First patient recruited in phase II/III trial of Toca-511/Toca-FC in high-grade glioma

Read More

Coordinated delivery of anticancer drug combinations reduces toxicity

Read More

Texas Biomedical Research Institute receives NIH grant to develop cure for HIV infection in infants

Read More

Stem Cell Medicine, Ramot and Yeda sign license agreement for stem cell treatments

Read More

Intravenous Taigexyn achieves primary endpoint in phase III trial in community-acquired pneumonia

Read More

Fluorescent tracer MB-102 devised for noninvasive glomerular filtration rate measurement

Read More

Novavax initiates phase III trial of RSV F vaccine

Read More

Biotest cleared for phase III evaluation of BT-524 fibrinogen concentrate

Read More

Cytos Biotechnology and Kuros Biosurgery combine to create Kuros Biosciences

Read More

EMA validates Gilead's MAA for fixed-dose sofosbuvir/velpatasvir

Read More

New inhibitors block Ewing's sarcoma cell growth in vitro and in vivo

Read More

Radiation sensitizer NVX-108 receives FDA orphan drug designation

Read More

Calibr discloses integrin alphavbeta6 receptor antagonists

Read More

MUSC Foundation for Research Development patents anticancer agents

Read More

Molecular Targeting Technologies and NHRI develop anticancer drug conjugates

Read More

SpsB inhibitors reported in RQx Pharmaceuticals patent

Read More

Genentech and Roche report retinoid RORgamma ligands

Read More

Sealife Pharma presents antibacterial agents

Read More

Multiple dosing begun in phase I trial of CCX-872-B in pancreatic cancer

Read More

Samsung Bioepis obtains Korean approval for Renflexis and updates pipeline status

Read More

First-in-human data for ASTX-727 in myelodysplastic syndromes presented at ASH

Read More

Eli Lilly to cease development of basal insulin peglispro

Read More

Consortium invests in Athera Biotechnologies to further development of PC-mAB

Read More

First response to a BET inhibitor seen in NUT midline carcinoma

Read More

Zymeworks and GSK enter collaboration and license agreement for Fc-engineered antibodies

Read More

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for June 11, 2025.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for June 11, 2025.
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for June 10, 2025
  • Red blood cells in an artery with cholesterol

    In two phase IIIs, Merck’s PCSK9 inhibitor cuts cholesterol

    BioWorld
    In two phase III studies, Merck & Co. Inc.’s oral, once monthly proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitor produced statistically significant...
  • Cancer cell in the cross-hairs

    Pan-cancer proteome atlas reveals new biomarkers and targets

    BioWorld Science
    An international group of scientists has completed the first draft of The Pan-Cancer Proteome Atlas (TPCPA). The project is based on mass spectrometry of 22...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2025. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing

BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Israel
    • Rise of obesity
    • Radiopharmaceuticals
    • Biosimilars
    • Aging
    • IVDs on the rise
    • Coronavirus
    • Artificial intelligence

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe